Resistance to host antimicrobial peptides is necessary for Salmonella virulence.
The production of antibacterial peptides is a host defense strategy used by various species, including mammals, amphibians, and insects. Successful pathogens, such as the facultative intracellular bacterium Salmonella typhimurium, have evolved resistance mechanisms to this ubiquitous type of host defense. To identify the genes required for resistance to host peptides, we isolated a library of 20,000 MudJ transposon insertion mutants of a virulent peptide-resistant S. typhimurium strain and screened it for hypersensitivity to the antimicrobial peptide protamine. Eighteen mutants had heightened susceptibility to protamine and 12 of them were characterized in detail. Eleven mutants were attenuated for virulence in vivo when inoculated into BALB/c mice by the intragastric route, and 8 of them were also avirulent following intraperitoneal inoculation. The mutants fell into different phenotypic classes with respect to their susceptibility to rabbit defensin NP-1, frog magainin 2, pig cecropin P1, and the insect venom-derived peptides mastoparan and melittin. The resistance loci mapped to eight distinct locations in the genome. Characterization of the mutants showed that one had a defective lipopolysaccharide and another mutant harbored a mutation in phoP, a locus previously shown to control expression of Salmonella virulence genes. Our data indicate that the ability to resist the killing effect of host antimicrobial peptides is a virulence property and that several resistance mechanisms operate in S. typhimurium.
Groisman
E A
EA
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Parra-Lopez
C
C
Salcedo
M
M
Lipps
C J
CJ
Heffron
F
F
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides; D005075:Biological Evolution; D001798:Blood Proteins / Q000494:pharmacology*; D002874:Chromosome Mapping; D003594:Cytoplasmic Granules / Q000737:chemistry; D023082:Defensins; D005798:Genes, Bacterial; D005838:Genotype; D006098:Granulocytes / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D054806:Magainins; D051379:Mice; D016296:Mutagenesis; D010455:Peptides / Q000494:pharmacology; D011479:Protamines / Q000494:pharmacology; D012480:Salmonella Infections / Q000382:microbiology*; D012486:Salmonella typhimurium / Q000235:genetics / Q000472:pathogenicity*; D029867:Xenopus Proteins
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; D023082:Defensins; D054806:Magainins; D010455:Peptides; D011479:Protamines; D029867:Xenopus Proteins; C053301:magainin 2 peptide, Xenopus